A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome

Clinical trial NCT00918411 · COMPLETED

Trial details

NCT number: NCT00918411
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Irritable Bowel Syndrome

Start date: 2009-06-01
Primary completion: 2009-12-01
Enrollment: 98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.